Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Genomics signatures in uterine cancers could offer clues to prognosis.
The impending Supreme Court ruling on gene patents is creating uncertainty in the molecular diagnostics sector.
A startup called Catabasis is developing drugs that hit diseases at multiple targets.